-DOCSTART-	
	
Understanding	O
transcriptional	B-Process
regulation	I-Process
of	O
pancreatic	B-Process
development	I-Process
is	O
required	O
to	O
advance	O
current	O
efforts	O
in	O
developing	O
beta	B-Process
cell	I-Process
replacement	I-Process
therapies	I-Process
for	O
patients	B-Material
with	I-Material
diabetes	I-Material
.	O
	
Current	O
knowledge	O
of	O
key	B-Material
transcriptional	I-Material
regulators	I-Material
has	O
predominantly	O
come	O
from	O
mouse	B-Process
studies	I-Process
,	O
with	O
rare	B-Process
,	I-Process
naturally	I-Process
occurring	I-Process
mutations	I-Process
establishing	O
their	O
relevance	O
in	O
man	O
.	O
	
This	O
study	O
used	O
a	O
combination	O
of	O
homozygosity	B-Process
analysis	I-Process
and	O
Sanger	B-Process
sequencing	I-Process
in	O
37	B-Data
consanguineous	B-Material
patients	I-Material
with	O
permanent	B-Process
neonatal	I-Process
diabetes	I-Process
to	O
search	O
for	O
homozygous	B-Process
mutations	I-Process
in	O
29	B-Data
transcription	B-Material
factor	I-Material
genes	I-Material
important	O
for	O
murine	B-Process
pancreatic	I-Process
development	I-Process
.	O
	
We	O
identified	O
homozygous	B-Process
mutations	I-Process
in	O
7	B-Data
different	B-Material
genes	I-Material
in	O
11	B-Data
unrelated	B-Material
patients	I-Material
and	O
show	O
that	O
NKX2	B-Material
-	I-Material
2	I-Material
and	O
MNX1	B-Material
are	O
etiological	B-Material
genes	I-Material
for	O
neonatal	B-Process
diabetes	I-Process
,	O
thus	O
confirming	O
their	O
key	O
role	O
in	O
development	B-Process
of	O
the	B-Material
human	I-Material
pancreas	I-Material
.	O
	
The	B-Data
similar	I-Data
phenotype	I-Data
of	O
the	B-Material
patients	I-Material
with	O
recessive	B-Process
mutations	I-Process
and	O
mice	B-Material
with	O
inactivation	B-Process
of	O
a	B-Material
transcription	I-Material
factor	I-Material
gene	I-Material
support	I-Material
there	O
being	O
common	O
steps	O
critical	O
for	O
pancreatic	B-Process
development	I-Process
and	O
validate	O
the	O
use	O
of	O
rodent	B-Material
models	I-Material
for	O
beta	B-Process
cell	I-Process
development	I-Process
.	O
	
Graphical	O
Abstract	O
Highlights	O
•	O
	
Homozygous	B-Process
mutations	I-Process
in	O
seven	B-Data
pancreatic	B-Data
transcription	I-Data
factors	I-Data
cause	O
neonatal	B-Process
diabetes	I-Process
•	O
	
Homozygous	B-Process
NKX2	I-Process
-	I-Process
2	I-Process
and	I-Process
MNX1	I-Process
mutations	I-Process
were	O
found	O
in	O
five	B-Material
patients	I-Material
•	O
Confirms	O
NKX2	B-Material
-	I-Material
2	I-Material
and	O
MNX1	B-Material
are	O
critical	O
for	O
murine	B-Process
and	I-Process
human	I-Process
pancreas	I-Process
development	I-Process
•	O
	
Similar	B-Data
phenotypes	I-Data
in	O
mouse	B-Material
and	O
man	B-Material
validate	B-Process
models	O
for	O
beta	B-Process
cell	I-Process
development	I-Process
Analyzing	O
a	B-Data
large	I-Data
collection	I-Data
of	O
consanguineous	B-Material
patients	I-Material
with	O
permanent	B-Process
neonatal	I-Process
diabetes	I-Process
,	O
Flanagan	O
et	O
al	O
.	O
performed	O
a	O
comprehensive	O
search	O
for	O
recessive	B-Process
mutations	I-Process
in	O
transcription	B-Data
factors	I-Data
known	O
to	O
be	O
critical	O
for	O
mouse	B-Process
pancreatic	I-Process
development	I-Process
.	O
	
They	O
identify	O
seven	B-Data
pancreatic	B-Data
transcription	I-Data
factors	I-Data
that	O
cause	O
neonatal	B-Process
diabetes	I-Process
,	O
including	O
NKX2	B-Material
-	I-Material
2	I-Material
and	O
MNX1	B-Material
.	O
	
